Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00083057. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06023875. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT04830592. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study)
ClinicalTrials.gov study NCT03695510. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas
ClinicalTrials.gov study NCT06642324. IPD Sharing: NO. Countries: 1. Publications: 4.
Feasibility of a Carbohydrate-restricted, High-fat Diet on Head and Neck Squamous Cell Carcinoma Outcomes
ClinicalTrials.gov study NCT04253808. IPD Sharing: NO. Countries: 1. Publications: 1.
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02438995. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab
ClinicalTrials.gov study NCT05075122. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
ClinicalTrials.gov study NCT06496178. IPD Sharing: Not stated. Countries: 24. Publications: 1.
CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04633278. IPD Sharing: YES. Countries: 1. Publications: 0.
One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02852343. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck
ClinicalTrials.gov study NCT02776137. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01538381. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05845632. IPD Sharing: NO. Countries: 1. Publications: 19.
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05909904. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00139243. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06082167. IPD Sharing: NO. Countries: 26. Publications: 1.
2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06492460. IPD Sharing: NO. Countries: 1. Publications: 21.
Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT05956795. IPD Sharing: NO. Countries: 1. Publications: 16.
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07010120. IPD Sharing: NO. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.